Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Medical Oncology
•
Hematology
•
Pediatric Hematology
•
Iron Homeostasis
•
Primary Care
What is your approach to screening a cancer survivor for iron overload, and what is your treatment of choice?
Answer from: at Community Practice
Excellent article on this topic: Baskin-Miller et al., PMID 39096194
Sign in or Register to read more
26026
Related Questions
In an adult patient with asymptomatic, isolated neutropenia in whom you suspect a Duffy null phenotype, at what ANC or in what situations would you do a bone marrow to look for other etiologies of neutropenia?
What are your top takeaways from ISTH 2025?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
In pure red cell aplasia, does peripheral blood-positive IgG for parvovirus have significance if persistently positive on retesting, but IgM and PCR are negative?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
How do you counsel an otherwise healthy patient on how soon they can go back to moderate exercise after a bilateral pulmonary embolism?
Would you supplement iron for low iron studies in absence of anemia?
How would you approach adjusting nivo+AVD therapy for advanced Hodgkin lymphoma if a patient develops treatment limited immunotherapy toxicity?
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?